Influence of CYP3A5 Polymorphism in Donor and Recipient on Tacrolimus Pharmacokinetics and Clinical Outcome after Renal Transplantation

被引：0
|
作者：
Cauffiez, Christelle [1 ]
Glowacki, Francois [2 ]
Lionet, Arnaud [2 ]
Provot, Francois [2 ]
Hazzan, Marc [2 ]
Noel, Christian [2 ]
Allorge, Delphine [1 ]
Broly, Franck [1 ]
机构：
[1] Univ Lille 2, Fac Med Pole Rech, EA2679, F-59800 Lille, France
[2] CHRU Lille, Hop Calmette, Lille, France
来源：
THERAPEUTIC DRUG MONITORING | 2009年 / 31卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
203
引用
收藏
页码：661 / 661
页数：1
相关论文
共 50 条
  • [21] Influence of CYP3A5 gene polymorphisms of donor rather than recipient to tacrolimus individual dose requirement in liver transplantation
    Yu, SF
    Wu, LH
    Jin, J
    Yan, S
    Jiang, GP
    Xie, HY
    Zheng, SS
    TRANSPLANTATION, 2006, 81 (01) : 46 - 51
  • [22] Influence of CYP3A5 Polymorphisms On Tacrolimus Pharmacokinetics and Renal Function in Renal Transplant Recipients.
    Salvador-Garrido, P.
    Outeda-Macias, M.
    Pedreira-Vazquez, I.
    Elberdin-Pazos, L.
    Fernandez-Rivera, C.
    Alonso-Hernandez, A.
    Martin-Herranz, I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 618 - 618
  • [23] Influence of CYP3A5 Polymorphisms On Tacrolimus Pharmacokinetics and Renal Function in Renal Transplant Recipients.
    Salvador-Garrido, P.
    Outeda-Macias, M.
    Pedreira-Vazquez, I.
    Elberdin-Pazos, L.
    Fernandez-Rivera, C.
    Alonso-Hernandez, A.
    Martin-Herranz, I.
    TRANSPLANTATION, 2014, 98 : 618 - 618
  • [24] Early clinical relevance of donor/recipient CYP3A5, CYP3A4 and ABCB1 polymorphisms after liver transplantation under tacrolimus immunosuppression
    Argudo-Ramirez, A.
    Gonzalez De Aledo, J. M.
    Ramirez, P.
    Castellote, J.
    Alia-Ramos, P.
    CLINICA CHIMICA ACTA, 2019, 493 : S641 - S641
  • [25] Tacrolimus dose requirement in pediatric liver transplantation: influence of CYP3A5 gene polymorphism
    Durand, Philippe
    Debray, Dominique
    Kolaci, Mikaela
    Bouligand, Jerome
    Furlan, Valerie
    Fabre, Monique
    Letierce, Alexia
    Verstuyft, Celine
    Becquemont, Laurent
    PHARMACOGENOMICS, 2013, 14 (09) : 1017 - 1025
  • [26] Influence of CYP3A5 Polymorphism on the Pharmacokinetics of Psychiatric Drugs
    Ragia, Georgia
    Dahl, Marja-Liisa
    Manolopoulos, Vangelis G.
    CURRENT DRUG METABOLISM, 2016, 17 (03) : 227 - 236
  • [27] AN EFFECT OF DONOR-RECIPIENT CYP3A5 GENOTYPE COMBINATION ON TACROLIMUS EXPOSURE IN RENAL TRANSPLANT RECIPIENTS
    Warzyszynska, Karola
    Karpeta, Edyta
    Kosieradzki, Maciej
    TRANSPLANT INTERNATIONAL, 2021, 34 : 257 - 257
  • [28] Impact of Donor and Recipient CYP3A5*3 Genotype on Tacrolimus Population Pharmacokinetics in Chinese Adult Liver Transplant Recipients
    Shao, Jia
    Wang, Chenyu
    Fu, Peng
    Chen, Fan
    Zhang, Yi
    Wei, Jinxia
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (07) : 652 - 661
  • [29] Influence of CYP3A5 polymorphism on tacrolimus maintenance doses and serum levels after renal transplantation: Age dependency and pharmacological interaction with steroids
    Ferraris, Jorge R.
    Argibay, Pablo F.
    Costa, Lucas
    Jimenez, Graciela
    Coccia, Paula A.
    Ghezzi, Lidia F. R.
    Ferraris, Veronica
    Belloso, Waldo H.
    Redal, Maria A.
    Larriba, Julian M.
    PEDIATRIC TRANSPLANTATION, 2011, 15 (05) : 525 - 532
  • [30] Influence of CYP3A5 polymorphisms on 5-year tacrolimus pharmacokinetics and renal function in renal transplant recipients
    Salvador, Pilar
    Outeda, Maria
    Pedreira, Isaura
    Fernandez, Constantino
    Alonso, Angel
    Martin, Isabel
    TRANSPLANTATION, 2016, 100 (07) : S710 - S710
12345